By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083




Company News
Kamada (KMDA) WIthdraws MAA For Inhaled Alpha-1 Antitrypsin 6/22/2017 5:44:55 AM
Kamada Ltd. (KMDA) Receives Additional Milestone Payment Under GLASSIA Exclusive Supply And Distribution Agreement With Shire (SHPG) 6/12/2017 12:01:24 PM
Kamada Ltd. (KMDA) Provides Update On Clinical Program For Alpha-1 Antitrypsin IV For Treatment Of Graft-Versus-Host Disease 6/7/2017 8:43:48 AM
Kamada Ltd. (KMDA) Announces Appointment Of Michal Stein, M.D., As Vice President And Medical Director 6/5/2017 1:35:25 PM
Kamada Ltd. (KMDA) Presents Updated Data From Phase II Clinical Trial Of Inhaled Alpha-1-Antitrypsin For Treatment Of Alpha-1 Antitrypsin Deficiency At 2017 American Thoracic Society International Conference 5/24/2017 11:19:31 AM
Kamada Ltd. (KMDA) Reports 2017 First Quarter Financial Results 5/16/2017 11:09:27 AM
Kamada Ltd. (KMDA) To Host First Quarter 2017 Financial Results Conference Call On May 16 5/8/2017 9:57:18 AM
Kamada Ltd. (KMDA) To Host R&D Day Focused On Graft Versus Host Disease (GvHD) 3/3/2017 11:02:43 AM
Kamada Ltd. (KMDA) Announces Collaboration With Massachusetts General Hospital For Proof Of Concept Study Evaluating Benefit Of Liquid Alpha-1 Antitrypsin On Liver Preservation Prior To Transplantation 2/21/2017 10:58:32 AM
Kamada Ltd. (KMDA) Announces Appointment Of Biopharmaceutical Industry Veteran, Gwen Melincoff, To Its Board Of Directors 2/8/2017 9:36:46 AM